Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Abdul G Hameed"'
Autor:
Nadine D. Arnold, Josephine A. Pickworth, Laura E. West, Sarah Dawson, Joana A. Carvalho, Helen Casbolt, Adam T. Braithwaite, James Iremonger, Lewis Renshall, Volker Germaschewski, Matthew McCourt, Philip Bland-Ward, Hager Kowash, Abdul G. Hameed, Alexander M. K. Rothman, Maria G. Frid, A. A. Roger Thompson, Holly R. Evans, Mark Southwood, Nicholas W. Morrell, David C. Crossman, Moira K. B. Whyte, Kurt R. Stenmark, Christopher M. Newman, David G. Kiely, Sheila E. Francis, Allan Lawrie
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-18 (2019)
Pulmonary arterial hypertension (PAH) is characterised by progressive pulmonary vascular remodelling. Here, Arnold et al. develop a therapeutic antibody targeting osteoprotegerin and find it attenuates pulmonary vascular remodelling in multiple roden
Externí odkaz:
https://doaj.org/article/fbbe9cf6fb44471db21ebf04ce2094b6
Autor:
Smitha Rajaram, Alexander M.K. Rothman, Andrew J. Swift, Christopher S. Johns, Jim M. Wild, Robin Condliffe, Abdul G. Hameed, David Capener, Charlie Elliot, Robert A. Lewis, Pankaj Garg, David G. Kiely, A. A. Roger Thompson, Athanasios Charalampopoulos
Publikováno v:
The International Journal of Cardiovascular Imaging
This study aimed to determine the prognostic value of cardiovascular magnetic resonance (CMR) in patients with heart failure with preserved ejection fraction and associated pulmonary hypertension (pulmonary hypertension-HFpEF). Patients with pulmonar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e561e5d38647d88f487908731da2802
https://ueaeprints.uea.ac.uk/id/eprint/82094/
https://ueaeprints.uea.ac.uk/id/eprint/82094/
Autor:
Jennifer Southern, Robin Condliffe, Charlie Elliot, Abdul G. Hameed, David G. Kiely, Catherine Billings, K. Bauchmuller, Athanasios Charalampopoulos, Roger Thompson, Ian Sabroe, Ajay Raithatha, Gary H. Mills
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Pulmonary hypertension (PH) is a life-shortening condition characterised by episodes of decompensation precipitated by factors such as disease progression, arrhythmias and sepsis. Surgery and pregnancy also place additional strain on the right ventri
Autor:
Robert Lewis, Iain Armstrong, Carmel Bergbaum, Melanie J Brewis, John Cannon, Athanasios Charalampopoulos, A Colin Church, J Gerry Coghlan, Rachel Davies, Konstantinos Dimopoulos, Charlie Elliot, J Simon R Gibbs, Wendy Gin-Sing, Gulam Haji, Abdul G Hameed, Luke S Howard, Martin K Johnson, Aleksander Kempny, David G Kiely, Francesco Lo Giudice, Colm Mccabe, Oyinkansola Peleyeju, Joanna Pepke-Zaba, Gary Polwarth, Laura Price, Ian Sabroe, Benjamin E Schreiber, Karen Sheares, Dolores Taboada, A A Roger Thompson, Mark R Toshner, Ivy Wanjiku, S John Wort, Janelle Yorke, Robin Condliffe
Health-related quality of life (HRQoL) scores assess symptom burden in pulmonary arterial hypertension (PAH) but data regarding their role in prognostication and risk stratification are limited. We assessed these relationships using the emPHasis-10 H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e2ee513c71e8133ba1808bcb8747e1
https://www.repository.cam.ac.uk/handle/1810/317873
https://www.repository.cam.ac.uk/handle/1810/317873
Autor:
Allan Lawrie, Abdul G. Hameed, Robin Condliffe, John Harrington, David G. Kiely, Ian A Smith, Catherine Billings, Jim M. Wild, Neil Hamilton, Iain Armstrong, Jennifer Middleton, A. A. Roger Thompson, Athanasios Charalampopoulos, Ian Sabroe, Robert A. Lewis, Judith Hurdman, Matthew Austin, Charlie Elliot, Alexander M.K. Rothman, Andrew J. Swift
Publikováno v:
Annals of the American Thoracic Society
Rationale: Exercise capacity predicts mortality in pulmonary arterial hypertension (PAH), but limited data exist on the routine use of maximal exercise testing.Objectives: This study evaluates a simple-to-perform maximal test (the incremental shuttle
Autor:
Robert A. Lewis, Judith Hurdman, A. A. Roger Thompson, Iain Armstrong, Ian Sabroe, Emma Drew, Athanasios Charalampopoulos, Catherine Billings, David G. Kiely, Abdul G. Hameed, Jim M. Wild, Alexander M.K. Rothman, Andrew J. Swift, Neil Hamilton, John Harrington, Robin Condliffe, Ian Smith, Allan Lawrie, Charlie Elliot, Jennifer Middleton, Matthew Austin, Tom Kelly
Publikováno v:
Pulmonary hypertension.
Autor:
Andrew J. Peacock, Robin Condliffe, Wendy Gin-Sing, Gary Polwarth, Carmel Bergbaum, Karen Sheares, Mark Toshner, Aleksander Kempny, Melanie J. Brewis, John Cannon, Ian Sabroe, J. Gerry Coghlan, Ivy Wanjiku, Dolores Taboada, J. Simon R. Gibbs, Oyinkansola Peleyeju, Robert A. Lewis, David G. Kiely, Janelle Yorke, Gulam Haji, Konstantinos Dimopoulos, Athanasios Charalampopoulos, Charlie Elliot, C. McCabe, Francesco Lo Giudice, Rachel J. Davies, Abdul G. Hameed, Luke S. Howard, Iain Armstrong, A. Colin Church, A. A. Roger Thompson, Joanna Pepke-Zaba, Laura C. Price, Benjamin E. Schreiber, S. John Wort, Martin Johnson
Publikováno v:
The European Respiratory Journal
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Health-related quality of life (HRQoL) scores assess symptom burden in pulmonary arterial hypertension (PAH) but data regarding their role in prognostication and risk stratification are limited. We assessed these relationships using the emPHasis-10 H
Autor:
Massimiliano Mazzone, Ananda S. Mirchandani, Simon J. Foster, David H. Dockrell, Peter Carmeliet, Emily R. Watts, Nadine Arnold, Joseph A Willson, Lynne Williams, Federico Taverna, Rebecca S. Dickinson, Pranvera Sadiku, Nicholas M. Morton, Catherine J. Doherty, A. A. Roger Thompson, Sarah R. Walmsley, Veronica Finisguerra, Edwin R. Chilvers, Amy Lewis, Shareen Forbes, Helen M. Marriott, Patricia Dos Santos Coelho, Randall S. Johnson, John P. Thomson, Moira K. B. Whyte, Julie A. Preston, Allan Lawrie, Fiona Murphy, Andrew S. Cowburn, Richard R. Meehan, Roland H Stimson, Jermaine Goveia, Abdul G. Hameed, Eilise M. Ryan, Adriana Tavares
Publikováno v:
Thompson, A A R, Dickinson, R S, Murphy, F, Thomson, J P, Marriott, H M, Tavares, A, Willson, J, Williams, L, Lewis, A, Mirchandani, A, Dos Santos Coelho, P, Doherty, C, Ryan, E, Watts, E, Morton, N M, Forbes, S, Stimson, R H, Hameed, A G, Arnold, N, Preston, J A, Lawrie, A, Finisguerra, V, Mazzone, M, Sadiku, P, Goveia, J, Taverna, F, Carmeliet, P, Foster, S J, Chilvers, E R, Cowburn, A S, Dockrell, D H, Johnson, R S, Meehan, R R, Whyte, M K B & Walmsley, S R 2017, ' Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism ', Science Immunology, vol. 2, no. 8, eaal2861 . https://doi.org/10.1126/sciimmunol.aal2861
Hypoxia and bacterial infection frequently coexist, in both acute and chronic clinical settings, and typically result in adverse clinical outcomes. To ameliorate this morbidity, we investigated the interaction between hypoxia and the host response. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b31b381051dc9e5a6366f78a268326
https://europepmc.org/articles/PMC5380213/
https://europepmc.org/articles/PMC5380213/
Autor:
Abdul G. Hameed
Publikováno v:
Journal of the American College of Cardiology. 69(2)
Mazzanti et al. [(1)][1] report a clinically important study on the benefits of mexiletine in reducing arrhythmic events in symptomatic patients with long QT syndrome type 3. Specifically, 3 of these 13 patients continued to have arrhythmic events (w
Autor:
Nadine Arnold, Lan Zhao, Simon S. Cross, Janet Chamberlain, David G. Kiely, David C. Crossman, Lu Long, Nicholas W. Morrell, Claudia Paiva, Josephine A. Pickworth, Allan Lawrie, Sarah Dawson, Chris Newman, Sheila E. Francis, Abdul G. Hameed
Publikováno v:
The Journal of Experimental Medicine
Genetic deletion of TRAIL or antibody blockade prevents the development of pulmonary arterial hypertension and can reverse vascular remodeling in established disease.
Pulmonary arterial hypertension (PAH) is a life-threatening disease characteri
Pulmonary arterial hypertension (PAH) is a life-threatening disease characteri